MLADEN NIKOLIC: Open Payments
NPI 1144736927 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 40 payments from 14 companies in 2025. Trend: 2023 $308 · 2024 $784 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $253 |
| Amgen Inc. | 11 | $216 |
| Lilly USA, LLC | 4 | $63 |
| ABBVIE INC. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 1 | $58 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Abbott Laboratories | 2 | $40 |
| Dynavax Technologies Corporation | 2 | $35 |
| Exact Sciences Corporation | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: Ozempic, REPATHA, Wegovy, OTEZLA, MOUNJARO, UBRELVY, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
